References
- Prasad Verma PR, Chandak AR. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance. Acta Pharm 2009;59:171–186.
- Betageri G, Habib M. Liposomes as drug carriers. Pharm Eng 1994;14:76–77.
- Handjani-Vila RM, Ribier A, Rondot B, Vanlerberghie G. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int j Cosmet Sci 1979;1:303–314.
- Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes–non-ionic surfactant vesicles. j Pharm Pharmacol 1985;37:863–868.
- Uchegbu IF. Some aspects of the niosomal delivery of doxorubicin. Ph.D. Thesis, University of London, England, 1994.
- Hofland HE, van der Geest R, Bodde HE, Junginger HE, Bouwstra JA. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm Res 1994;11:659–664.
- Van Hal DA, Bouwstra JA,Van Rensen A,Jeremiasse E,De Vringer T,Junginger HE. Preparation and characterization of nonionic surfactant vesicles. J Coll Interf Sci 1996;178:263–273.
- Schreier H, Bouwstra JA. Liposomes and niosomes as drug carriers: dermal and transdermal drug delivery. J Control Rel 1994;30:1–15.
- Junginger HE, Hofland HEJ, Bouwstra JALiposomes and niosomes interactions with human skin. Cosmet Toil 1991; 106:45–50.
- Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int j Pharm 2006;311:11–19.
- Mura S, Pirot F, Manconi M, Falson F, Fadda AM. Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. j Drug Target 2007;15:101–108.
- Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res 1995;44:423–433.
- Lipscomb GR, Wallis N, Armstrong G, Rees WD. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study. Br j Clin Pharmacol 1998;46:133–137.
- Degner F, Sigmund R, Zeidler H. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease. Clin Ther 2000;22:400–410.
- Ah YC, Choi JK, Choi YK, Ki HM, Bae JH. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int j Pharm 2010;385:12–19.
- Han HK, Choi HK. Improved absorption of meloxicam via salt formation with ethanolamines. Eur j Pharm Biopharm 2007;65:99–103.
- Luger P, Daneck K, Engel W, Trummlitz G, Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci 1996;4:175–187.
- Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. j Mol Biol 1965;13:238–252.
- Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int j Pharm 2008;360:156–163.
- Abbas P, Jaleh V, Abdolhossein R. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 2007;328:130–141.
- Azeem A, Ahmad FJ, Khan ZI, Talegaonkar S. Nonionic surfactant vesicles as a carrier for transdermal delivery of frusemide. J Dispers Sci Technol 2008;29:723–730.
- Ngawhirunpat T, Opanasopit P, Rojanarata T, Akkaramongkolporn P, Ruktanonchai U, Supaphol P. Development of meloxicam-loaded electrospun polyvinyl alcohol mats as a transdermal therapeutic agent. Pharm Dev Technol 2009;14:70–79.
- Chang C, Yang Y, Yang J, Wu H, Tsai T. Absorption and emission spectral shifts of rose bengal associated with DMPC liposomes. Dyes Pigments 2008;79:170–175.
- Wada Y, Etoh Y, Ohira A, Kimata H, Koide T, Ishihama H et al. Percutaneous absorption and anti-inflammatory activity of indomethacin in ointment. j Pharm Pharmacol 1982;34:467–468.
- Balata GF, 1999. Formulation and evaluation of certain anti-inflammatory drugs in emulgels. Master Thesis, faculty of pharmacy, Zagazig university, Egypt.
- Institute of Laboratory Animal Resources. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996.
- Kamio K, Sakai M, Kaminaga A, Satake I, Hayakawa K. Colloid Polym Sci 2002;280:78.
- Bernsdorff C, Wolf A, Winter R, Gratton E. Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid-cholesterol bilayers. Biophys j 1997;72:1264–1277.
- Kirby C, Clarke J, Gregoriadis G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem j 1980;186:591–598.
- Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. j Control Release 2000;65:403–418.
- Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000;21:1879–1885.
- Lasic D, Weiner N, Riaz M, Martin F. Liposomes. In: Lieberman A, Rieger M, Banker G,. Pharmaceutical Dosage Forms: Disperse Systems. New York: vol 3, Marcel Dekker, 1998, pp. 8–43.
- Namdeo A, Jain NK. Niosomes as drug carriers. Ind J Pharm Sci 1996;58:41–46.
- Touitou E, Junginger HE, Weiner ND, Nagai T, Mezei M. Liposomes as carriers for topical and transdermal delivery. j Pharm Sci 1994;83:1189–1203.
- Uchegbu IF, Vyas SP. Nonionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998;172:33–70.
- Obata Y, Takayama K, Maitani Y, Machida Y, Nagai T. Effect of ethanol on the permeation of ionized and non ionized declofenac. Int J Pharm 1993;89:191–198.
- Megrab AN, William AC, Barry BW. Oestradiol permeation across human skin, silastic and snak skin membranes: the effect of ethanol: water co-solvent systems. Int J Pharm 1995;116:101–112.